<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CINACALCET HYDROCHLORIDE</span><br/>(sin-a'ca-let)<br/><span class="topboxtradename">Sensipar<br/></span><b>Classifications:</b> <span class="classification">hormones &amp; synthetic substitutes</span>; <span class="classification"> parathyroid agent</span>; <span class="classification">calcium receptor agonist</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>30 mg, 60 mg, 90 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Directly lowers parathyroid hormone (PTH) levels by increasing the sensitivity of calcium-sensing receptors on the parathyroid
         gland to extracellular calcium. The reduction in PTH causes decreased calcium and phosphate adsorption from bone, and thus
         decreased serum calcium and phosphate levels. The drug is a calcium receptor agonist, also known as a calcimimetic agent.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Lowers PTH production; this also decreases rate of bone turnover and bone fibrosis in chronic renal failure disease (CRFD).</p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; hypercalcemia in patients
         with parathyroid cancer.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to cinacalcet; pregnancy (category C), lactation, children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Moderate and severe hepatic impairment, hypocalcemia, history of seizures.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Secondary Hyperparathyroidism</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> Start with 30 mg once daily; may increase q24wk until target iPTH of 150300 pg/mL (max: 300 mg/d)<br/><br/><span class="indicationtitle">Parathyroid Cancer</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 30 mg twice daily; titrate q24wk as 60 mg b.i.d., 90 mg b.i.d., then 90 mg 34 times daily as needed to normalize
               calcium concentrations<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">
<b>Oral</b>
</span><br/><ul>
<li>Give with food or shortly after a meal.</li>
<li>Tablets should be swallowed whole and not divided, crushed, or chewed.</li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Dizziness, asthenia, non-cardiac chest pain, dialysis access infection. <span class="typehead"> CV:</span>  Hypertension. <span class="typehead"> GI:</span>
<span class="speceff-common">Nausea, vomiting, diarrhea</span>
<i>, </i>anorexia. <span class="typehead">Metabolic:</span> Hypocalcemia. <span class="typehead">Musculoskeletal:</span>
<span class="speceff-common">Myalgia</span>
<i>,</i> adynamic bone disease (renal osteodystrophy). 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  May increase <b>amoxapine, atomoxetine, carvedilol, metoprolol, propranolol, timolol, encainide, flecainide, mexiletine, propafenone, clozapine,
         codeine, cyclobenzaprine, fenfluramine, dexfenfluramine, dextromethorphan, donepezil, fluoxetine, haloperidol, hydrocodone,
         maprotiline, meperidine, methadone, methamphetamine, morphine, oxycodone, paroxetine, perphenazine, risperidone, thioridazine</b> (use may be contraindicated with cinacalcet), <b>tramadol, trazodone,</b> tricyclic antidepressants, <b>venlafaxine, zolpidem</b> levels; cinacalcet levels may be increased by strong CYP3A4 inhibitors such as <b>fluconazole, itraconazole, ketoconazole, miconazole, voriconazole, clarithromycin, erythromycin, dalfopristin; quinupristin,
         troleandomycin, verapamil, diltiazem, amiodarone, aprepitant, fluvoxamine, nefazodone, zafirlukast, zileuton</b>
<b>.</b>
<span class="typehead">Food:</span>
<b>Grapefruit juice</b> may increase cinacalcet levels. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Peak:</span> 26 h. <span class="typehead">Distribution:</span>  9397% protein bound. <span class="typehead">Metabolism:</span> Metabolized in liver by CYP3A4. <span class="typehead">Elimination:</span> 80% excreted by kidneys, 15% excreted in feces. <span class="typehead">Half-Life:</span> 3040 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for S&amp;S of hypocalcemia (e.g., paresthesias, myalgias, cramping, tetany, convulsions).</li>
<li>Withhold drug and notify physician for serum calcium 
         </li><li>Lab tests: Serum calcium and phosphorus within 1 wk after and iPTH 14 wk after initiation of drug or dose adjustment;
            thereafter, monthly serum calcium and phosphorus (more often with a history of a seizure disorder), and iPTH every 13
            mo.
         </li>
<li>Closely monitor iPTH and serum calcium with concurrent administration of a strong CYP3A4 (e.g., ketoconazole, erythromycin,
            itraconazole).
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report promptly any of the following: seizure or convulsion; muscle spasms or cramping of the abdomen, back, legs, face; burning,
            numbness, pricking, tickling, or tingling of the face, lips, tongue, hands, or feet; changes in mental status.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>